在卡塔尔国家制定糖尿病研究议程
Amit Mishra1, Suresh Babu Kokku1, Ioanna Skaroni1,2
1National Diabetes Strategy Department of Non-Communicable Diseases Prevention Programs Ministry of Public Health Doha Qatar.
Public health challenges
|June 11, 2025
概括
卡塔尔制定了一项国家糖尿病研究议程,以应对中东和北非 (MENA) 地区糖尿病的高患病率. 该议程优先考虑预防,早期检测,逆转,治疗和系统研究,以改善结果.
科学领域:
- 生物医学研究生物医学研究
- 公共卫生 公共卫生
- 内分泌学 在内分泌学.
背景情况:
- 中东和北非 (MENA) 地区的非传染性疾病负担很高,包括糖尿病.
- 卡塔尔的糖尿病患病率高达16.7%.
- 在过去二十年中,卡塔尔对生物医学研究基础设施进行了大量投资.
研究的目的:
- 记录卡塔尔制定国家糖尿病研究议程的过程.
- 建立卡塔尔糖尿病研究的战略方向.
- 将研究工作与国家卫生重点协调一致.
主要方法:
- 对糖尿病研究出版物的图书统计分析,以评估当前的趋势和资金.
- 深入采访和全国咨询研讨会,以确定挑战和解决方案.
- 专家团队对建议进行同化,以完成议程.
主要成果:
- 糖尿病研究出版物和国际合作 (48个国家) 的增长趋势.
- 主要来自队列研究的病因研究占出版物的49%.
- 优先考虑五个主要研究领域:预防,早期检测,逆转,治疗开发/评估和系统研究.
结论:
- 议程制定过程确定了关键的知识缺口和有影响力的研究领域.
- 加强合作,持续融资和强有力的监管框架对于实现议程目标至关重要.
- 完成的议程为科研界提供了关于卡塔尔高优先级糖尿病研究的指导.
相关概念视频
01:15Diabetes: Management and Pharmacotherapy
244
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
244
01:23Dipeptidyl Peptidase 4 Inhibitors
178
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
178